Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels

Ronald A. Li, Irene L. Ennis, Gordon F. Tomaselli, Eduardo Marbán

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Voltage-gated Na+ channels underlie rapid conduction in heart and skeletal muscle. Cardiac sodium channels open and close over more negative potentials than do skeletal muscle sodium channels; heart channels are also more sensitive to lidocaine block. The structural basis of these differences is poody understood. We mutated nine isoform-specific υ1 (rat skeletal muscle) channel residues in domain IV to those at equivalent locations in hH1 (human cardiac) channels. Channel constructs were expressed in tsA-201 cells and screened for changes in gating and lidocaine sensitivity. Only L1373E, located in the linker between the S1 and S2 transmembrane segments, shifted activation gating and use-dependent block by lidocaine toward that seen in hH1. The converse mutation, hH1-E1555L, shifted the phenotype of hill to resemble that of υ1. Therefore, we identified a previously unsuspected glutamate-to-leucine isoform-specific variant site (i.e., 1555 in hH1 and 1373 in υ1) that significantly influences gating and drug block in sodium channels. The identification of the residue at this position plays a major role in shaping the responses of sodium channels to voltage and to lidocaine, helping to rationalize the distinctive behavior of cardiac sodium channels.

Original languageEnglish (US)
Pages (from-to)136-141
Number of pages6
JournalMolecular Pharmacology
Volume61
Issue number1
DOIs
StatePublished - Jan 19 2002
Externally publishedYes

Fingerprint

Sodium Channels
Lidocaine
Myocardium
Protein Isoforms
Skeletal Muscle
Leucine
Glutamic Acid
Phenotype
Mutation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology

Cite this

Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels. / Li, Ronald A.; Ennis, Irene L.; Tomaselli, Gordon F.; Marbán, Eduardo.

In: Molecular Pharmacology, Vol. 61, No. 1, 19.01.2002, p. 136-141.

Research output: Contribution to journalArticle

@article{99a21b6f93ce4d6e909e7cf380a4be8d,
title = "Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels",
abstract = "Voltage-gated Na+ channels underlie rapid conduction in heart and skeletal muscle. Cardiac sodium channels open and close over more negative potentials than do skeletal muscle sodium channels; heart channels are also more sensitive to lidocaine block. The structural basis of these differences is poody understood. We mutated nine isoform-specific υ1 (rat skeletal muscle) channel residues in domain IV to those at equivalent locations in hH1 (human cardiac) channels. Channel constructs were expressed in tsA-201 cells and screened for changes in gating and lidocaine sensitivity. Only L1373E, located in the linker between the S1 and S2 transmembrane segments, shifted activation gating and use-dependent block by lidocaine toward that seen in hH1. The converse mutation, hH1-E1555L, shifted the phenotype of hill to resemble that of υ1. Therefore, we identified a previously unsuspected glutamate-to-leucine isoform-specific variant site (i.e., 1555 in hH1 and 1373 in υ1) that significantly influences gating and drug block in sodium channels. The identification of the residue at this position plays a major role in shaping the responses of sodium channels to voltage and to lidocaine, helping to rationalize the distinctive behavior of cardiac sodium channels.",
author = "Li, {Ronald A.} and Ennis, {Irene L.} and Tomaselli, {Gordon F.} and Eduardo Marb{\'a}n",
year = "2002",
month = "1",
day = "19",
doi = "10.1124/mol.61.1.136",
language = "English (US)",
volume = "61",
pages = "136--141",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels

AU - Li, Ronald A.

AU - Ennis, Irene L.

AU - Tomaselli, Gordon F.

AU - Marbán, Eduardo

PY - 2002/1/19

Y1 - 2002/1/19

N2 - Voltage-gated Na+ channels underlie rapid conduction in heart and skeletal muscle. Cardiac sodium channels open and close over more negative potentials than do skeletal muscle sodium channels; heart channels are also more sensitive to lidocaine block. The structural basis of these differences is poody understood. We mutated nine isoform-specific υ1 (rat skeletal muscle) channel residues in domain IV to those at equivalent locations in hH1 (human cardiac) channels. Channel constructs were expressed in tsA-201 cells and screened for changes in gating and lidocaine sensitivity. Only L1373E, located in the linker between the S1 and S2 transmembrane segments, shifted activation gating and use-dependent block by lidocaine toward that seen in hH1. The converse mutation, hH1-E1555L, shifted the phenotype of hill to resemble that of υ1. Therefore, we identified a previously unsuspected glutamate-to-leucine isoform-specific variant site (i.e., 1555 in hH1 and 1373 in υ1) that significantly influences gating and drug block in sodium channels. The identification of the residue at this position plays a major role in shaping the responses of sodium channels to voltage and to lidocaine, helping to rationalize the distinctive behavior of cardiac sodium channels.

AB - Voltage-gated Na+ channels underlie rapid conduction in heart and skeletal muscle. Cardiac sodium channels open and close over more negative potentials than do skeletal muscle sodium channels; heart channels are also more sensitive to lidocaine block. The structural basis of these differences is poody understood. We mutated nine isoform-specific υ1 (rat skeletal muscle) channel residues in domain IV to those at equivalent locations in hH1 (human cardiac) channels. Channel constructs were expressed in tsA-201 cells and screened for changes in gating and lidocaine sensitivity. Only L1373E, located in the linker between the S1 and S2 transmembrane segments, shifted activation gating and use-dependent block by lidocaine toward that seen in hH1. The converse mutation, hH1-E1555L, shifted the phenotype of hill to resemble that of υ1. Therefore, we identified a previously unsuspected glutamate-to-leucine isoform-specific variant site (i.e., 1555 in hH1 and 1373 in υ1) that significantly influences gating and drug block in sodium channels. The identification of the residue at this position plays a major role in shaping the responses of sodium channels to voltage and to lidocaine, helping to rationalize the distinctive behavior of cardiac sodium channels.

UR - http://www.scopus.com/inward/record.url?scp=0036144123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036144123&partnerID=8YFLogxK

U2 - 10.1124/mol.61.1.136

DO - 10.1124/mol.61.1.136

M3 - Article

C2 - 11752214

AN - SCOPUS:0036144123

VL - 61

SP - 136

EP - 141

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -